Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.46 USD | -1.10% |
|
-3.77% | -17.30% |
Jun. 03 | Tranche Update on Copart, Inc.'s Equity Buyback Plan announced on February 20, 2003. | CI |
May. 23 | JPMorgan Adjusts Price Target on Copart to $55 From $60, Maintains Neutral Rating | MT |
Fiscal Period: July | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 16.99 | 17.72 | 17.41 | 15.42 | 12.97 | |||||
Return on Total Capital | 19.67 | 20.13 | 19.55 | 17.12 | 14.28 | |||||
Return On Equity % | 32.8 | 31.12 | 26.74 | 23.32 | 20.13 | |||||
Return on Common Equity | 32.8 | 31.12 | 26.74 | 23.32 | 20.18 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 45.69 | 51.16 | 46.87 | 45.73 | 45.77 | |||||
SG&A Margin | 8.69 | 8.95 | 7.6 | 7.31 | 8.64 | |||||
EBITDA Margin % | 41.13 | 46.38 | 42.95 | 42.35 | 41.41 | |||||
EBITA Margin % | 37.4 | 42.46 | 39.49 | 38.74 | 37.45 | |||||
EBIT Margin % | 37 | 42.21 | 39.28 | 38.42 | 37.13 | |||||
Income From Continuing Operations Margin % | 31.73 | 34.78 | 31.14 | 31.99 | 32.15 | |||||
Net Income Margin % | 31.73 | 34.78 | 31.14 | 31.99 | 32.17 | |||||
Net Avail. For Common Margin % | 31.73 | 34.78 | 31.14 | 31.99 | 32.17 | |||||
Normalized Net Income Margin | 22.64 | 26.01 | 24.22 | 25.08 | 25.29 | |||||
Levered Free Cash Flow Margin | 4.42 | 11.08 | 15.59 | 15.08 | 17.38 | |||||
Unlevered Free Cash Flow Margin | 4.86 | 11.51 | 15.87 | 15.08 | 17.37 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.73 | 0.67 | 0.71 | 0.64 | 0.56 | |||||
Fixed Assets Turnover | 1.28 | 1.21 | 1.41 | 1.41 | 1.37 | |||||
Receivables Turnover (Average Receivables) | 25.61 | 30 | 31.5 | 27.73 | 27.37 | |||||
Inventory Turnover (Average Inventory) | 58.4 | 40.43 | 35.85 | 42.53 | 54.96 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.71 | 4.04 | 5 | 6.62 | 7.03 | |||||
Quick Ratio | 1.67 | 2.76 | 3.57 | 5.15 | 5.74 | |||||
Operating Cash Flow to Current Liabilities | 2.58 | 2.35 | 2.67 | 2.77 | 2.34 | |||||
Days Sales Outstanding (Average Receivables) | 14.29 | 12.17 | 11.59 | 13.16 | 13.37 | |||||
Days Outstanding Inventory (Average Inventory) | 6.27 | 9.03 | 10.18 | 8.58 | 6.66 | |||||
Average Days Payable Outstanding | 37.74 | 40.34 | 34.13 | 32.2 | 29.69 | |||||
Cash Conversion Cycle (Average Days) | -17.19 | -19.14 | -12.36 | -10.45 | -9.66 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 20.81 | 14.68 | 2.58 | 2.01 | 1.57 | |||||
Total Debt / Total Capital | 17.23 | 12.8 | 2.52 | 1.97 | 1.55 | |||||
LT Debt/Equity | 19.79 | 14.04 | 2.11 | 1.65 | 1.29 | |||||
Long-Term Debt / Total Capital | 16.38 | 12.25 | 2.06 | 1.62 | 1.27 | |||||
Total Liabilities / Total Assets | 27.95 | 22.64 | 12.87 | 11.14 | 10.43 | |||||
EBIT / Interest Expense | 40.34 | 56.13 | 82.39 | - | - | |||||
EBITDA / Interest Expense | 46.91 | 63.38 | 92.2 | - | - | |||||
(EBITDA - Capex) / Interest Expense | 17.64 | 40.51 | 71.98 | - | - | |||||
Total Debt / EBITDA | 0.55 | 0.4 | 0.08 | 0.07 | 0.07 | |||||
Net Debt / EBITDA | 0.04 | -0.41 | -0.82 | -1.34 | -1.85 | |||||
Total Debt / (EBITDA - Capex) | 1.45 | 0.63 | 0.1 | 0.1 | 0.09 | |||||
Net Debt / (EBITDA - Capex) | 0.11 | -0.65 | -1.05 | -1.94 | -2.59 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 8.01 | 22.08 | 30.02 | 10.53 | 9.49 | |||||
Gross Profit, 1 Yr. Growth % | 12.18 | 31.23 | 19.13 | 7.82 | 9.6 | |||||
EBITDA, 1 Yr. Growth % | 14.28 | 37.67 | 20.42 | 8.98 | 7.04 | |||||
EBITA, 1 Yr. Growth % | 13.48 | 38.59 | 20.92 | 8.42 | 5.85 | |||||
EBIT, 1 Yr. Growth % | 13.9 | 39.25 | 20.99 | 8.11 | 5.83 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 18.29 | 33.8 | 16.41 | 13.54 | 10.07 | |||||
Net Income, 1 Yr. Growth % | 18.29 | 33.8 | 16.41 | 13.54 | 10.12 | |||||
Normalized Net Income, 1 Yr. Growth % | 13.83 | 40.23 | 21.1 | 14.42 | 10.44 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 19.11 | 33.11 | 15.9 | 13.27 | 9.38 | |||||
Accounts Receivable, 1 Yr. Growth % | 4.22 | 4.23 | 42.63 | 13.6 | 8.54 | |||||
Inventory, 1 Yr. Growth % | -4.11 | 123.94 | 30.74 | -32.01 | 9.17 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 44.56 | 17.26 | 7.65 | 13.44 | 11.38 | |||||
Total Assets, 1 Yr. Growth % | 35.63 | 32.03 | 16.37 | 26.92 | 25.08 | |||||
Tangible Book Value, 1 Yr. Growth % | 51.3 | 49.34 | 33.44 | 32.76 | 25.42 | |||||
Common Equity, 1 Yr. Growth % | 39.99 | 41.76 | 31.07 | 29.44 | 25.66 | |||||
Cash From Operations, 1 Yr. Growth % | 41.95 | 7.95 | 18.75 | 15.94 | 7.94 | |||||
Capital Expenditures, 1 Yr. Growth % | 58.33 | -21.79 | -27.12 | 53.1 | -1.09 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -10.46 | 203.6 | 82.89 | 6.94 | 26.16 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -11.22 | 188.99 | 79.29 | 5.02 | 26.11 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 10.52 | 14.83 | 25.99 | 19.88 | 10.01 | |||||
Gross Profit, 2 Yr. CAGR % | 14.98 | 21.77 | 27.6 | 14.78 | 9.88 | |||||
EBITDA, 2 Yr. CAGR % | 17.38 | 25.43 | 28.76 | 14.56 | 8.01 | |||||
EBITA, 2 Yr. CAGR % | 17.31 | 25.41 | 29.45 | 14.5 | 7.13 | |||||
EBIT, 2 Yr. CAGR % | 18.06 | 25.94 | 29.8 | 14.37 | 6.97 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 29.4 | 25.81 | 24.8 | 14.96 | 11.79 | |||||
Net Income, 2 Yr. CAGR % | 29.42 | 25.81 | 24.8 | 14.96 | 11.82 | |||||
Normalized Net Income, 2 Yr. CAGR % | 18.83 | 26.34 | 30.32 | 17.72 | 12.41 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 30.14 | 25.91 | 24.2 | 14.87 | 11.31 | |||||
Accounts Receivable, 2 Yr. CAGR % | -14.35 | 4.23 | 21.93 | 27.29 | 11.04 | |||||
Inventory, 2 Yr. CAGR % | 9.54 | 46.54 | 71.11 | -5.72 | -13.84 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 33.3 | 30.2 | 12.35 | 10.51 | 12.4 | |||||
Total Assets, 2 Yr. CAGR % | 22.36 | 33.82 | 23.95 | 21.53 | 26 | |||||
Tangible Book Value, 2 Yr. CAGR % | 33.63 | 50.32 | 41.17 | 33.1 | 29.04 | |||||
Common Equity, 2 Yr. CAGR % | 25.48 | 40.87 | 36.31 | 30.25 | 27.54 | |||||
Cash From Operations, 2 Yr. CAGR % | 30.98 | 23.79 | 13.22 | 17.34 | 11.87 | |||||
Capital Expenditures, 2 Yr. CAGR % | 43.39 | 11.28 | -24.5 | 5.63 | 23.06 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -23.44 | 64.55 | 135.64 | 39.85 | 16.16 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -22.5 | 60.18 | 127.62 | 37.22 | 15.08 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 15.06 | 14.25 | 19.69 | 20.61 | 16.31 | |||||
Gross Profit, 3 Yr. CAGR % | 15.05 | 21.8 | 20.89 | 20.64 | 13.02 | |||||
EBITDA, 3 Yr. CAGR % | 19.84 | 23.79 | 23.74 | 21.8 | 12 | |||||
EBITA, 3 Yr. CAGR % | 19.17 | 24.01 | 23.89 | 22.02 | 11.54 | |||||
EBIT, 3 Yr. CAGR % | 19.3 | 24.74 | 24.27 | 22.13 | 11.45 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 21.08 | 30.85 | 22.59 | 20.93 | 13.31 | |||||
Net Income, 3 Yr. CAGR % | 21.09 | 30.86 | 22.59 | 20.93 | 13.33 | |||||
Normalized Net Income, 3 Yr. CAGR % | 20.24 | 25.58 | 24.57 | 24.79 | 15.24 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 20.85 | 31.12 | 22.48 | 20.45 | 13.01 | |||||
Accounts Receivable, 3 Yr. CAGR % | -6.02 | -8.56 | 15.72 | 19.09 | 20.71 | |||||
Inventory, 3 Yr. CAGR % | 25.48 | 39.03 | 41.07 | 25.8 | -1 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 29.9 | 27.72 | 22.2 | 12.71 | 10.8 | |||||
Total Assets, 3 Yr. CAGR % | 20.34 | 25.51 | 27.73 | 24.93 | 22.7 | |||||
Tangible Book Value, 3 Yr. CAGR % | 45.92 | 38.67 | 44.47 | 38.31 | 30.49 | |||||
Common Equity, 3 Yr. CAGR % | 31.37 | 30.69 | 37.52 | 33.98 | 28.7 | |||||
Cash From Operations, 3 Yr. CAGR % | 23.1 | 22.8 | 22.09 | 14.12 | 14.12 | |||||
Capital Expenditures, 3 Yr. CAGR % | 50.93 | 17.16 | -3.36 | -4.44 | 3.34 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -17.79 | 21.54 | 70.45 | 81.08 | 35.13 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -17.34 | 20.18 | 66.31 | 75.89 | 33.41 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 13.99 | 16.25 | 19.31 | 16.47 | 15.72 | |||||
Gross Profit, 5 Yr. CAGR % | 14.65 | 19.33 | 19.92 | 18.34 | 15.86 | |||||
EBITDA, 5 Yr. CAGR % | 18.63 | 22.84 | 23.33 | 20.01 | 17.19 | |||||
EBITA, 5 Yr. CAGR % | 18.63 | 22.63 | 23.18 | 20.12 | 16.89 | |||||
EBIT, 5 Yr. CAGR % | 18.83 | 22.83 | 23.39 | 20.49 | 17.04 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 26.07 | 28.21 | 22.56 | 24.25 | 18.15 | |||||
Net Income, 5 Yr. CAGR % | 26.07 | 28.21 | 22.56 | 24.26 | 18.16 | |||||
Normalized Net Income, 5 Yr. CAGR % | 19.26 | 23.16 | 24.17 | 22.37 | 19.56 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 28.39 | 28.57 | 22.18 | 24.24 | 17.88 | |||||
Accounts Receivable, 5 Yr. CAGR % | 4.42 | 2.16 | 4.3 | 4.38 | 13.82 | |||||
Inventory, 5 Yr. CAGR % | 18.45 | 34.05 | 42.06 | 19.02 | 15.82 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 24.66 | 24.87 | 22.57 | 20.53 | 18.18 | |||||
Total Assets, 5 Yr. CAGR % | 13.95 | 22.56 | 21.77 | 23.9 | 27.03 | |||||
Tangible Book Value, 5 Yr. CAGR % | 26.09 | 45.63 | 44 | 36.42 | 38.09 | |||||
Common Equity, 5 Yr. CAGR % | 20.88 | 35.44 | 33.32 | 30.51 | 33.44 | |||||
Cash From Operations, 5 Yr. CAGR % | 28.2 | 24.41 | 19.05 | 20.59 | 17.89 | |||||
Capital Expenditures, 5 Yr. CAGR % | 49.54 | 21.63 | 14.41 | 12.4 | 6.45 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -9.64 | 21.18 | 25.49 | 28.56 | 46.21 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -8.9 | 19.37 | 23.96 | 26.73 | 43.53 |
- Stock Market
- Equities
- CPRT Stock
- Financials Copart, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions